Changping and Kexing Holdings signed a contract!

On July 24, the Changping District Government and Kexing Holdings Biotechnology Co., Ltd. signed a strategic cooperation agreement. At the same time, the SinoVac Koh Mcax Vaccine Quality Research Center officially started. Gan Jingzhong, Secretary of the District Party Committee, Vice Secretary of the District Party Committee and the district chief, Wang Lei, deputy director of the Municipal Economic and Information Bureau, Qu Haopeng, deputy director of the Municipal Drug Administration, and Yin Weidong, chairman, president and CEO of Kexing Holdings Biotechnology Co., Ltd., attended the signing ceremony.

At the ceremony, Yin Weidong introduced the company's development and growth process, capital strength, and the advantages of the pharmaceutical and health industry, and the prospects of Changping project. At the same time, thanks to the long -term support and help of the Changping District Party Committee and the District Government, he said that in the future, the Kexing Company will develop and produce more vaccines and drugs with the further support of the Changping District Party Committee and the District Government to help Changping District build the construction High -precision industrial cluster, creating a "Valley of Life" with a world -leading level, helping the construction of Beijing International Science and Technology Innovation Center.

Changping is the new city of the capital development of the capital, and it is also an important carrying area of ​​the Beijing Construction International Science and Technology Innovation Center. In recent years, our district has focused on scientific and technological innovation, with the future science city as its core, accelerating the creation of "Life Valley" and "Energy Valley" with international influence, and cultivating three trillion -dollar leading industries for medical health, advanced energy, and intelligent manufacturing Clusters, especially in the field of pharmaceutical and health industry, have brought together more than 500 innovative enterprises. In terms of consulting approval, space guarantee, employee recruitment, logistics transportation, etc., use the Changping speed and Changping temperature to serve the new crown vaccine, antibody drugs, and diagnostic reagents to help them overcome the bottlenecks and make bigger and stronger. In 2021, the regional regulatory pharmaceutical and health enterprises achieved revenue of 71.71 billion yuan, an increase of 22%year -on -year, and the industrial development was vibrant.

District leaders Yang Renquan and Liu Xiaodong attended the signing ceremony.

Text/Wang Hongtu/Mu Haoxing

- END -